Preparation and Properties of Serum and Plasma Proteins. IV. A System for the Separation into Fractions of the Protein and Lipoprotein Components of Biological Tissues and Fluids 1a,b,c,d, J Am Chem Soc. mars, vol.68, issue.3, pp.459-75, 1946. ,
, Pediatrics. juin, vol.9, issue.6, pp.722-730, 1952.
Highdose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood, Lancet Lond Engl. 6 juin, vol.1, issue.8232, pp.1228-1259, 1981. ,
Immunoglobulines polyvalentes : évaluation du bon usage, Pharm Hosp Clin. juin, vol.49, issue.2, p.67, 2014. ,
Changing trends in IVIG use in pediatric patients: A retrospective review of practices in a network of major USA pediatric hospitals, Int Immunopharmacol, vol.76, p.105868, 2019. ,
Intravenous Immunoglobin Utilization Study in a Teaching Hospital, Arch Iran Med. 1 mai, vol.22, issue.5, pp.232-237, 2019. ,
Human Immunoglobulin Versus Plasmapheresis in Guillain-Barre Syndrome and Myasthenia Gravis: A Meta-Analysis, J Clin Neuromuscul Dis. sept, vol.18, issue.1, pp.1-11, 2016. ,
,
,
,
, Diagnostic : [_______________________________________________________________________________________________________] Date de diagnostic
, Motif de la concertation :?initiation de traitement ? renouvellement Traitements antérieurs
,
, Décision (cf. verso de la fiche)
, Si refus, autre traitement proposé
, Si autorisation, dose préconisée